RJA
MR

Raymond James & Associates’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Raymond James & Associates’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-32,901
Closed -$1.2M – 2177
2013
Q4 		$1.2M Sell
32,901
-53,004
-62% -$2.06M 0.01% 1227
2013
Q3 		$3.34M Buy
85,905
+10,230
+14% +$412K 0.03% 641
2013
Q2 		$2.83M Buy
+75,675
New +$2.99M 0.03% 651

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Raymond James & Associates's MR Position: Q1 2014 in Review

Raymond James & Associates sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2014, closing a stake of 32,901 shares — an estimated $1.2M sold.

Raymond James & Associates first reported a position in MR in Q2 2013 and held it in 3 quarters. The position peaked at $3.34M in Q3 2013. 153 funds tracked by Wall St. Rank hold MR as of Q1 2014.

  • Raymond James & Associates reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2014 after selling out during the quarter.
  • Raymond James & Associates sold 32,901 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2014, an estimated $1.2M.
  • Raymond James & Associates first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 3 quarters.
  • Raymond James & Associates's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $3.34M in Q3 2013.
  • 153 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2014.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.